4//SEC Filing
SCICLONE PHARMACEUTICALS INC 4
Accession 0001181431-13-046025
CIK 0000880771operating
Filed
Aug 21, 8:00 PM ET
Accepted
Aug 22, 1:36 PM ET
Size
8.1 KB
Accession
0001181431-13-046025
Insider Transaction Report
Form 4
Yin Min
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2013-08-20$4.23/sh+12,500$52,875→ 12,500 total - Sale
Common Stock
2013-08-20$5.50/sh−12,500$68,750→ 0 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2013-08-20−12,500→ 12,500 totalExercise: $4.23Exp: 2021-11-01→ Common Stock (12,500 underlying)
Footnotes (2)
- [F1]Granted under the Issuer's 2005 Equity Incentive Plan.
- [F2]The Options vested 100% based on the achievement of certain peformance targets achieved prior to December 31, 2013.
Documents
Issuer
SCICLONE PHARMACEUTICALS INC
CIK 0000880771
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000880771
Filing Metadata
- Form type
- 4
- Filed
- Aug 21, 8:00 PM ET
- Accepted
- Aug 22, 1:36 PM ET
- Size
- 8.1 KB